U.S. Markets closed

Whether it’s from "Moderna or one of the others" positive data is a good sign: Analyst

Raymond James Healthcare Policy Analyst Chris Meekins joins Yahoo Finance’s On The Move panel to address how Moderna is faring after the latest test results for its coronavirus vaccine.